719 related articles for article (PubMed ID: 24055703)
1. Impact of partial volume effect correction on cerebral β-amyloid imaging in APP-Swe mice using [(18)F]-florbetaben PET.
Brendel M; Delker A; Rötzer C; Böning G; Carlsen J; Cyran C; Mille E; Gildehaus FJ; Cumming P; Baumann K; Steiner H; Haass C; Herms J; Bartenstein P; Rominger A
Neuroimage; 2014 Jan; 84():843-53. PubMed ID: 24055703
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal assessment of cerebral β-amyloid deposition in mice overexpressing Swedish mutant β-amyloid precursor protein using 18F-florbetaben PET.
Rominger A; Brendel M; Burgold S; Keppler K; Baumann K; Xiong G; Mille E; Gildehaus FJ; Carlsen J; Schlichtiger J; Niedermoser S; Wängler B; Cumming P; Steiner H; Herms J; Haass C; Bartenstein P
J Nucl Med; 2013 Jul; 54(7):1127-34. PubMed ID: 23729696
[TBL] [Abstract][Full Text] [Related]
3. Partial-Volume Effect Correction Improves Quantitative Analysis of 18F-Florbetaben β-Amyloid PET Scans.
Rullmann M; Dukart J; Hoffmann KT; Luthardt J; Tiepolt S; Patt M; Gertz HJ; Schroeter ML; Seibyl J; Schulz-Schaeffer WJ; Sabri O; Barthel H
J Nucl Med; 2016 Feb; 57(2):198-203. PubMed ID: 26541776
[TBL] [Abstract][Full Text] [Related]
4. Cross-sectional comparison of small animal [18F]-florbetaben amyloid-PET between transgenic AD mouse models.
Brendel M; Jaworska A; Grießinger E; Rötzer C; Burgold S; Gildehaus FJ; Carlsen J; Cumming P; Baumann K; Haass C; Steiner H; Bartenstein P; Herms J; Rominger A
PLoS One; 2015; 10(2):e0116678. PubMed ID: 25706990
[TBL] [Abstract][Full Text] [Related]
5. Improved longitudinal [(18)F]-AV45 amyloid PET by white matter reference and VOI-based partial volume effect correction.
Brendel M; Högenauer M; Delker A; Sauerbeck J; Bartenstein P; Seibyl J; Rominger A;
Neuroimage; 2015 Mar; 108():450-9. PubMed ID: 25482269
[TBL] [Abstract][Full Text] [Related]
6. PETPVE12: an SPM toolbox for Partial Volume Effects correction in brain PET - Application to amyloid imaging with AV45-PET.
Gonzalez-Escamilla G; Lange C; Teipel S; Buchert R; Grothe MJ;
Neuroimage; 2017 Feb; 147():669-677. PubMed ID: 28039094
[TBL] [Abstract][Full Text] [Related]
7. [
Stenzel J; Rühlmann C; Lindner T; Polei S; Teipel S; Kurth J; Rominger A; Krause BJ; Vollmar B; Kuhla A
Curr Alzheimer Res; 2019; 16(1):49-55. PubMed ID: 30345916
[TBL] [Abstract][Full Text] [Related]
8. Amyloid-PET predicts inhibition of de novo plaque formation upon chronic γ-secretase modulator treatment.
Brendel M; Jaworska A; Herms J; Trambauer J; Rötzer C; Gildehaus FJ; Carlsen J; Cumming P; Bylund J; Luebbers T; Bartenstein P; Steiner H; Haass C; Baumann K; Rominger A
Mol Psychiatry; 2015 Oct; 20(10):1179-87. PubMed ID: 26055427
[TBL] [Abstract][Full Text] [Related]
9. Impact of MRI-based Segmentation Artifacts on Amyloid- and FDG-PET Quantitation.
Högenauer M; Brendel M; Delker A; Därr S; Weiss M; Bartenstein P; Rominger A; Alzheimer's Disease Neuroimaging Initiative
Curr Alzheimer Res; 2016; 13(5):597-607. PubMed ID: 27025775
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal evaluation of a novel BChE PET tracer as an early
Rejc L; Gómez-Vallejo V; Joya A; Moreno O; Egimendia A; Castellnou P; Ríos-Anglada X; Cossío U; Baz Z; Passannante R; Tobalina-Larrea I; Ramos-Cabrer P; Giralt A; Sastre M; Capetillo-Zarate E; Košak U; Knez D; Gobec S; Marder M; Martin A; Llop J
Theranostics; 2021; 11(13):6542-6559. PubMed ID: 33995675
[No Abstract] [Full Text] [Related]
11. Assessment of brain beta-amyloid deposition in transgenic mouse models of Alzheimer's disease with PET imaging agents
Son HJ; Jeong YJ; Yoon HJ; Lee SY; Choi GE; Park JA; Kim MH; Lee KC; Lee YJ; Kim MK; Cho K; Kang DY
BMC Neurosci; 2018 Jul; 19(1):45. PubMed ID: 30053803
[TBL] [Abstract][Full Text] [Related]
12. Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer's disease and healthy controls.
Barthel H; Luthardt J; Becker G; Patt M; Hammerstein E; Hartwig K; Eggers B; Sattler B; Schildan A; Hesse S; Meyer PM; Wolf H; Zimmermann T; Reischl J; Rohde B; Gertz HJ; Reininger C; Sabri O
Eur J Nucl Med Mol Imaging; 2011 Sep; 38(9):1702-14. PubMed ID: 21547601
[TBL] [Abstract][Full Text] [Related]
13. PET quantification of 18F-florbetaben binding to β-amyloid deposits in human brains.
Becker GA; Ichise M; Barthel H; Luthardt J; Patt M; Seese A; Schultze-Mosgau M; Rohde B; Gertz HJ; Reininger C; Sabri O
J Nucl Med; 2013 May; 54(5):723-31. PubMed ID: 23471310
[TBL] [Abstract][Full Text] [Related]
14. The importance of appropriate partial volume correction for PET quantification in Alzheimer's disease.
Thomas BA; Erlandsson K; Modat M; Thurfjell L; Vandenberghe R; Ourselin S; Hutton BF
Eur J Nucl Med Mol Imaging; 2011 Jun; 38(6):1104-19. PubMed ID: 21336694
[TBL] [Abstract][Full Text] [Related]
15. PET imaging of brain with the beta-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer's disease.
Toyama H; Ye D; Ichise M; Liow JS; Cai L; Jacobowitz D; Musachio JL; Hong J; Crescenzo M; Tipre D; Lu JQ; Zoghbi S; Vines DC; Seidel J; Katada K; Green MV; Pike VW; Cohen RM; Innis RB
Eur J Nucl Med Mol Imaging; 2005 May; 32(5):593-600. PubMed ID: 15791432
[TBL] [Abstract][Full Text] [Related]
16. Reshaping the Amyloid Buildup Curve in Alzheimer Disease? Partial-Volume Effect Correction of Longitudinal Amyloid PET Data.
Rullmann M; McLeod A; Grothe MJ; Sabri O; Barthel H;
J Nucl Med; 2020 Dec; 61(12):1820-1824. PubMed ID: 32358089
[TBL] [Abstract][Full Text] [Related]
17. Partial volume correction in arterial spin labeling perfusion MRI: A method to disentangle anatomy from physiology or an analysis step too far?
Chappell MA; McConnell FAK; Golay X; Günther M; Hernandez-Tamames JA; van Osch MJ; Asllani I
Neuroimage; 2021 Sep; 238():118236. PubMed ID: 34091034
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of early-phase [
Daerr S; Brendel M; Zach C; Mille E; Schilling D; Zacherl MJ; Bürger K; Danek A; Pogarell O; Schildan A; Patt M; Barthel H; Sabri O; Bartenstein P; Rominger A
Neuroimage Clin; 2017; 14():77-86. PubMed ID: 28138429
[TBL] [Abstract][Full Text] [Related]
19. Preclinical and clinical study on [
Xu M; Guo J; Gu J; Zhang L; Liu Z; Ding L; Fu H; Ma Y; Liang S; Wang H
Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):652-663. PubMed ID: 34292345
[TBL] [Abstract][Full Text] [Related]
20. Optimal Reference Region to Measure Longitudinal Amyloid-β Change with
Bullich S; Villemagne VL; Catafau AM; Jovalekic A; Koglin N; Rowe CC; De Santi S
J Nucl Med; 2017 Aug; 58(8):1300-1306. PubMed ID: 28183994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
